Gleevec Linked to Heart Failure

Staff Writer
Contributor
Posted by Staff WriterJuly 27, 2006 1:28 PM

Jamie Sheller at Philadelphia Personal Injury Lawyer brings my attention to the news that Gleevec, a successful treatment for chronic myelogenous leukemia, had been linked to congestive heart failure in rare cases.

Ten CML patients treated with Gleevec at the M.D. Anderson Cancer Center in Houston developed congestive heart failure, although they had normal heart function when they began taking the drug. Studies in mice and in culture showed that the Abl tyrosine kinase protects cardiac cells from damage; when it is inhibited, heart cells die.

Read the full Gleevec story from MedPage today.

0 Comments

Have an opinion about this post? Please consider leaving a comment or subscribing to the feed to have future articles delivered to your feed reader.

Comments for this article are closed.

Subscribe to InjuryBoard Jefferson City

InjuryBoard Jefferson City RSS Feeds

Keep up with the latest updates using your favorite RSS reader

Legal Assistance Center

More Info
Better Business Bureau Accredited Business Confidential

Your question will be referred to an attorney near you. If your question is of a legal nature, then by submitting this form you agree you are not forming a formal attorney / client relationship. Read our full privacy policy.

Looking for an InjuryBoard attorney closer to home? Click here.

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address